ReviewFoods (Basel, Switzerland)2025
Nature's Cardioprotective Sweetness: A Review of Dates as Functional Food in Hypertension.
Review in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dates, Polyunsaturated Fatty Acids, Dietary Fiber, and Probiotics as Potential Complementary Modulators of Gut Microbiota and Oxidative Stress: An Integrative Review.Antioxidants (Basel, Switzerland) · 2026Review
- Preliminary Prediction of Potential Hepatoprotective Properties of Jujube Extract in Rats Using Metabolomics and Bioinformatics.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dates contain numerous beneficial nutrients and bioactive compounds, including potassium, magnesium, dietary fiber, polyphenols, flavonoids, and essential fatty acids, which contribute to their antihypertensive effects. Mechanistically, these bioactives reduce oxidative stress, lower inflammation, enhance endothelial function through increased nitric oxide bioavailability, and modulate the renin-angiotensin system. Clinical studies demonstrate that regular, moderate consumption of dates can reduce systolic and diastolic blood pressure, improve lipid profiles, and positively regulate inflammatory and oxidative biomarkers without adverse metabolic or glycemic outcomes. Despite promising findings, variability in date cultivars, ripening stages, and limited standardized human trials necessitate further research. Larger, randomized clinical studies across diverse demographics are recommended to establish optimal dosage, confirm mechanisms of action, and assess long-term safety and effectiveness. This review investigates the potential of dates (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.